The influence of trans-resveratrol and quercetin on the activity of CYP1A2 in rat

Czech Journal of Food Sciences

Volumn 26, Issue SPEC. ISS., 2008, Pages

  Zendulka, Ondřej ^a   Zahradníková, Lucia ^a   Juřica, Jan ^a   Totušek, Jiří ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

Author keywords

CYP 1A2; Quercetin; Rat; Trans resveratrol

Indexed keywords

RATTUS;

EID: 62249170568     PISSN: 12121800     EISSN: None     Source Type: Journal    
DOI: 10.17221/244/2008-cjfs     Document Type: Conference Paper

References (22)

1. ANZENBACHER P., ANZENBACHEROVA E. (2001): Cytochromes P450 and metabolism of xenobiotics. Cellular and Molecular Life Sciences, 58: 737-747.
2. BOWERS J.L., TYULMENKOV V.V., JERNIGAN S.C., KLINGE C.M. (2000): Resveratrol acts as a mixed agonist/antagonist for estrogen receptor alpha and beta. Endocrinology, 141: 3657-3667.
3. BRAVO L. (1998): Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutrition Reviews, 56: 317-333.
4. CHAN W.K., DELUCCHI A.B. (2000): Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4. Life Sciences, 67: 3103-3112.
5. CIOLINO H.P., DASCHNER P.J., YEH G.C. (1999): Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochemical Journal, 340: 715-722.
6. DEVORE N.M., SMITH B.D., URBAN M.J., SCOTT E.E. (2008): Key residues controlling phenacetin metabolism by human cytochrome P450 2A enzymes. Drug metabolism and disposition, in press, http://dmd.aspetjournals. org/cgi/reprint/dmd.l08.023770v1 2.10.2008
7. HAMMONS G.J., YAN-SANDERS Y., JIN B., BLANN E., KADLUBAR F.F., LYN-COOK B.D. (2001): Specific site methylation in the 5'-flanking region of CYP 1A2 interindividual differences in human livers. Life Sciences, 69: 839-845.
8. HE Q., LV Y., YAO K. (2007): Effects of tea polyphenols on the activities of α amylase, pepsin, trypsin and lipase. Food Chemistry, 101: 1178-1182.
9. KLUTH D., BANNING A., PAUR I., BLOMHOFF R., BRIGELIUS-FLOHE R. (2007): Modulation of pregnane X receptor and electrophile responsive element-mediated gene expression by dietary polyphenolic compounds. Free Radical Biology & Medicine, 42: 315-325.
10. MILLER L.L., BLY G.G., WATSON N.M., BALE W.F. (1951): The dominant role of the liver in plasma protein synthesis; a direct study of the isolated perfused rat liver with the aid of lysin-epsilon-C14. Journal of Experimental Medicine, 94: 431-453.
11. OBACH R.S. (2000): Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. Journal of Pharmacology and Experimental Therapeutics, 294: 88-95.
12. PIVER B., BERTHOU F., DREANO Y., LUCAS D. (2003): Differential inhibition of human cytochrome P450 enzymes by epsilon-viniferin, the dimer of resveratrol: comparison with resveratrol and polyphenols from alcoholized beverages. Life Sciences, 73: 1199-1213.
13. RAHDEN-STARON I., CZECZOT H., SZUMILO M. (2001): Induction of rat liver cytochrome P450 isoenzymes CYP1A and CYP2B by different fungicides, nitrofurans, and quercetin. Mutation Research/Genetic Toxicology and Enviromental Mutagenesis, 498: 54-66.
14. REGEV-SHOSHAIN G., SHOSHEYOV O., KEREM Z. (2004): Influence of liphophilicity on the interactions of hydroxy stilbenes with cytochrome P450 3A4. Biochemical and Biophysical Research Communications, 323: 668-673.
15. RECHNER A.R., KUHNLE G., BREMNER P., HUBBARD G.P., MOORE K.P., RICE-EVANS C.A. (2002): The metabolic fate of dietary polyphenols in humans. Free Radical Biology and Medicine, 33: 220-235.
16. SABU M.C., SMITHA K., KUTTAN R. (2002): Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. Journal of Ethnopharmacology, 83: 109-116.
17. SCANDLYN M.J., STUART E.G., ROSENGREN R.J. (2008): Sex-specific differences in CYP450 isoforms in humans. Expert Opinion on Drug Metabolism and Toxicology, 4: 413-424.
18. SELISKAR M., ROZMAN D. (2007): Mammalian cytochromes P450-importance of tissue specificity. Biochimica et Biophysica Acta, 1770: 458-466.
19. SESSO H.D., GAZIANO J.M., LIU S., BURING J.E. (2003): Flavonoid intake and the risk of cardiovascular disease in women. American Journal of Clinical Nutrition, 77: 1400-1408.
20. TERRA X., MONTAGUT G., BUSTOS M., LLOPIZ N., ARDEVOLL A., BLADE C., FERNANDEZ-LARREA J., PUJADAS G., SALVADO J., AROLA L., BLAY M. (2008): Grape-seed procyanidins prevent low grade inflammation by modulating cytokine expression in rats fed a high-fat diet. Journal of Nutritional Biochemistry, in press, http://www.sciencedirect. com/ science?_ob=ArticleURL&_udi=B6T8P-4SXRTM1-4&_user=835458&_rdoc= l&_fmt=&_orig=search&_sort=d&view=c&_acct =C000045159&_version=1&_urlVersion=0&_userid=835458&md5= 7976551aO 25292eOdf0791924c3160a7-2.10.2008
21. TSYRLOV I.B., MIKHAILENKO V.M., GELBOIN H.V. (1994): Isozyme- and species-specific susceptibility of cDNA-expressed CYP 1A P-450s to different flavonoids. Biochimical et Biophysical Acta, 1205: 325-335.
22. VAN LIPZIG M.M.H., VERMEULEN, N.P.E., GUSINU R., LEGLER J., FRANK H., SEIDEL A., MEERMAN, J.H.N. (2005): Formation of estrogenic metabolites of benzo[a]pyrene and chrysene by cytochrome P450 activity and their combined and supra-maximal estrogenic activity. Environmental Toxicology and Pharmacology, 19: 41-55.